InsidersTradesSigma
Track the CODEXIS INC share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €257.7m. The latest transaction was disclosed on 12 February 2016 (Retenue fiscale). Among the most active insiders: Lalonde James. All data is accessible without an account.
Analysts rate CODEXIS INC Buy (bullish), based on 6 analysts. Average price target: US$6.58.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations
CODEXIS INC is a biotechnology company focused on developing enzymatic solutions for various sectors, including healthcare and agriculture.